相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Radiation therapy with tositumomab (B1) anti-CD20 monoclonal antibody initiates extracellular signal-regulated kinase/mitogen-activated protein kinase-dependent cell death that overcomes resistance to apoptosis
Andrey Ivanov et al.
CLINICAL CANCER RESEARCH (2008)
Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice
Chang-Yun Hu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Rituximab-CD20 complexes are shaved from Z138 mantle cell lymphoma cells in intravenous and subcutaneous SCID mouse models
Yongli Li et al.
JOURNAL OF IMMUNOLOGY (2007)
Mechanisms of killing by anti-CD20 monoclonal antibodies
Martin J. Glennie et al.
MOLECULAR IMMUNOLOGY (2007)
Depletion of B cells in murine lupus: Efficacy and resistance
Anupama Ahuja et al.
JOURNAL OF IMMUNOLOGY (2007)
The CCL3 family of chemokines and innate immunity cooperate in vivo in the eradication of an established lymphoma xenograft by rituximab
Elena Cittera et al.
JOURNAL OF IMMUNOLOGY (2007)
Exchanging human Fcγ1 with murine Fcγ2a highly potentiates anti-tumor activity of anti-EpCAM antibody adecatumumab in a syngeneic mouse lung metastasis model
Petra Lutterbuese et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Antibodies, Fc receptors and cancer
Falk Nimmerjahn et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20
Jessica L. Teeling et al.
JOURNAL OF IMMUNOLOGY (2006)
B-cell targeting in rheumatoid arthritis and other autoimmune diseases
JCW Edwards et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Role of target geometry in phagocytosis
JA Champion et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Antibody isotype-specific engagement of Fcγ receptors regulates B lymphocyte depletion during CD20 immunotherapy
Y Hamaguchi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
The carbohydrate at FcγRIIIa Asn-162 -: an element required for high affinity binding to non-fucosylated IgG glycoforms
C Ferrara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Divergent immunoglobulin G subclass activity through selective Fc receptor binding
F Nimmerjahn et al.
SCIENCE (2005)
Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas
RI Fisher et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Efficacy and safety of tositumomab and iodine-131 tositumomab (Bexxar) in B-Cell lymphoma, progressive after rituximab
SJ Horning et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy
Q Gong et al.
JOURNAL OF IMMUNOLOGY (2005)
The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy
JJ Uchida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Complement activation determines the therapeutic activity of rituximab in vivo
N Di Gaetano et al.
JOURNAL OF IMMUNOLOGY (2003)
Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: Relationship to in vivo rituximab resistance
R Bannerji et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Alanine-170 and proline-172 are critical determinants for extracellular CD20 epitopes; heterogeneity in the fine specificity of CD20 monoclonal antibodies is defined by additional requirements imposed by both amino acid sequence and quaternary structure
MJ Polyak et al.
BLOOD (2002)
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
G Cartron et al.
BLOOD (2002)
Complement activation plays a key role in the side-effects of rituximab treatment
LE van der Kolk et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma
WK Weng et al.
BLOOD (2001)
Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcγRII
NR Pritchard et al.
CURRENT BIOLOGY (2000)